ampelopsin has been researched along with galangin in 3 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (galangin) | Trials (galangin) | Recent Studies (post-2010) (galangin) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 366 | 0 | 238 |
| Protein | Taxonomy | ampelopsin (IC50) | galangin (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 35.5 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 8.56 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 9 | |
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.077 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.04 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.13 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.65 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 1.8 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.014 | |
| Aurora kinase B | Homo sapiens (human) | 9.8 | |
| Short transient receptor potential channel 5 | Homo sapiens (human) | 0.45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, K; Irie, K; Katayama, S; Masuda, Y; Murakami, K; Nakagawa, Y; Sato, M; Takegoshi, K; Uno, M | 1 |
| Busquets, MA; Espargaró, A; Estelrich, J; Ginex, T; Luque, FJ; Muñoz-Torrero, D; Sabate, R; Vadell, MD | 1 |
| Basu, S; Das, S; Majumder, T; Mukherjee, P; Sarkar, A | 1 |
3 other study(ies) available for ampelopsin and galangin
| Article | Year |
|---|---|
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Catechols; Humans; Lysine; Norleucine; Peptide Fragments; Quercetin | 2013 |
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Apigenin; Benzaldehydes; Cinnamates; Depsides; Flavonoids; Humans; In Vitro Techniques; Molecular Structure; Peptide Fragments; Phenols; Quercetin; Rosmarinic Acid | 2017 |
Flavonoids as BACE1 inhibitors: QSAR modelling, screening and in vitro evaluation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Disaccharides; Flavonoids; Flavonols; Humans; Molecular Docking Simulation; Neurons; Oxidative Stress; Plaque, Amyloid; Protein Conformation; Quantitative Structure-Activity Relationship; Quercetin | 2020 |